Become a Corporate Partner Following incredible achievements in 2021, NephCure begins 2022 introducing new initiatives and building on the success of core organizational programs. Last year, NephCure unveiled the Corporate Partnership program in response to the ever-growing desire of companies in this space to engage with patients in their discovery process while also elevating the collective rare kidney disease community. This endeavor has created a wonderful win-win situation that enables NephCure to both carry out key programmatic offerings and launch new activities that address stakeholder needs. This year, NephCure will continue to focus on clinical trial awareness, advocacy, health equity, and patient and physician education. NephCure will continue to empower patients through its Regional Community structure, educate and support physicians on treating glomerular disease patients through GlomCon, and focus on clinical trial awareness and connections to expert nephrologists via KidneyHealthGateway.com. Additionally, NephCure will bolster advocacy efforts and introduce a meaningful legislative agenda to drive policy change and help improve the lives of patient families. Please see our partnership opportunities for 2022 below. If interested in these opportunities, please reach out to Rebecca Cook for more information. LEARN MORE LEARN MORE